Hematogenous metastasis of ovarian cancer: rethinking mode of spread. - Test2 - elhamkhani - TriplyDB

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

http://www.wikidata.org/entity/Q33908024

about

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.Erythropoietin Stimulates Tumor Growth via EphB4.Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.Expression and Function of CD44 in Epithelial Ovarian Carcinoma Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling.Targeting the tumour microenvironment in ovarian cancer Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.The biological significance and clinical applications of exosomes in ovarian cancer.Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement.Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.The Unique Molecular and Cellular Microenvironment of Ovarian Cancer Prediction of therapy response in ovarian cancer: Where are we now?Immunological Functions of the Omentum.Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment

P2860

Q26738643-E4EB0FF5-3C21-4946-A94C-BF325B3D97FB Q26769963-AA50943D-420A-4559-BD3F-68F933386B0D Q26780387-A520D744-3BAA-4C70-ABDF-9361E5AEEC60 Q26781924-28804237-D09C-4AA5-9D7A-5A4545B08788 Q28071987-F5118F67-ED1C-4C2E-BC56-D37D6AC7C9E7 Q33829859-6BB4920B-7A11-482C-BF46-9644CE5B940C Q33838714-A1C59E47-96C6-4E04-A292-F7D39B7DB66F Q33872469-ADF495F6-CACC-44A2-ADD0-F414827BB977 Q33872622-0576611B-F52E-46FB-BA04-84EC1F1C2048 Q34528553-6FAAFFDA-EF1E-4306-BD09-59FDB2327857 Q35768450-6E2C8EBB-AB3C-436A-83BA-2E4DFBE883F2 Q36122605-9CB1E24F-FFB5-440B-9D4D-A0C0C297E468 Q36180735-5E40BE52-9E61-4399-BBB1-59496E89AF42 Q36275814-CF73AC21-71C8-4DCA-BA8C-D638B4934806 Q36405508-09536E5D-BE37-4665-BE01-9EDCB2D8794D Q36409587-1CA55E73-F2F8-42E8-840B-87E3C5EC5E64 Q36557500-104C3763-FFDD-4550-88AD-83E5202DF288 Q36626921-75E35C75-C156-4923-87D7-A6F94B386FCD Q36729513-1B41F9CD-BE47-460D-8F85-EBDFA0ABEB13 Q36759360-7754782C-F92C-46F9-8D5F-C370EA5AD96E Q36768803-9F8E1437-6E97-4454-85CB-EBACDC29035D Q37029851-B3D9003E-86AC-42BA-BB78-AF29CE2735E6 Q37109600-D46ED4C9-0D35-4150-A8F2-7E0910187BA0 Q37395811-B5A3385D-6EA9-46D6-A7CE-6A17CD15CF01 Q37620476-05F98062-B1FA-46D8-B6AA-F155B758C51B Q37706054-67805DE4-2E34-4AEC-91B5-81E052E99177 Q38669394-B6BB5F62-A405-4C78-A9BE-6CBEABC8EC8D Q38698820-C41233A7-B2BE-4F48-B551-EFEF535354B7 Q38715123-78A4C0C5-0147-4327-95D0-1B1216604D86 Q38734229-249B188D-2BF4-4EE6-B6E5-DD23A8485446 Q38736435-EA19BA81-B1B8-403A-B44F-6B755838F712 Q38767850-862C0D19-900A-4B9F-B247-94AE5F65BAD6 Q38777812-AB938BC8-2911-4F71-9F49-2F025F4F18CB Q38787442-C571EB90-093E-4661-B763-8E4986296833 Q38826628-D9C400C3-A156-42A5-81F6-658FB49D1C8A Q39169603-A4DBFFD5-4156-44AB-B323-9EDB4A9E0F57 Q39263260-C52A3A5E-AD2B-4B32-8266-1DC3F7A36B02 Q39349334-9F6794DE-170F-4021-BA4E-C58BCE7B471C Q39636313-D0AA6312-5D2E-45A7-85B7-D626C38E964D Q41341695-2E51820C-AA86-4FD6-BF3F-2D9C3149DB30

P2860

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

http://www.wikidata.org/entity/Q33908024

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@ast

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@en

type

label

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@ast

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@en

prefLabel

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@ast

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@en

P1433

Q33908024-A30B3BCD-8800-4400-950D-DAA63CCAC56B

P1476

Q33908024-0DC99FD5-D5FF-41DA-8CFE-3CEB0697C7F7

P2093

Q33908024-13CADD85-736E-4047-B23C-1A13191A3F43

Q33908024-15488521-CB24-46CA-B0AA-F76639AF29B5

Q33908024-1D2D6AC6-3386-4CCC-80B2-EAD2C80737FE

Q33908024-2A94C94B-35D8-4958-B1D7-A1137E04B8B7

Q33908024-2B5D56E9-5BC0-4500-9E1C-370E1D2A8530

Q33908024-2CEAF923-B43A-489C-9FF7-2B2BC89C7E30

Q33908024-2D2548CE-6819-4EE4-88EC-F4A8DE274858

Q33908024-304F06F4-7A93-4066-B231-572C3EA7E616

Q33908024-31BC9633-5252-4D76-B6D8-709CA277A028

Q33908024-3E139A5A-DC9B-4088-966A-48D344FFB7CA

P2860

Q33908024-00983B67-165D-4688-A8C8-9E25C6945AEE

Q33908024-13235D78-B0E8-40E7-B256-88472D6D4210

Q33908024-13DB4318-594C-40D4-9637-FADEF5C40894

Q33908024-176125A5-994F-4FF5-AF41-D973982E9C5A

Q33908024-1C33F308-02DB-45FC-BDC0-F0BAF8BABA0D

Q33908024-1D93C112-BD3B-4651-ADDC-9F573FE57450

Q33908024-21EB05D7-47A1-4DA5-93BA-7021512DE808

Q33908024-267FF458-134C-497B-9495-2203E2F938B2

Q33908024-339AE96C-47B4-4A57-947A-A88CC1F34D37

Q33908024-346DC4FA-F5B6-4BA0-83E1-D17B58EF3CB3

P304

Q33908024-0CDC8324-7B74-45AF-BC6A-56AF473516E9

P31

Q33908024-26A1B042-1973-4170-B157-1C8DD60DE9DE

P356

Q33908024-0E2EF1AC-7E09-44A1-B8E7-683EB9BE4C8A

P433

Q33908024-6F61AC7B-E979-454B-9D13-13AC89A4DF91

P478

Q33908024-77BF802B-1C0D-4D21-B638-90256B67A1EB

P50

Q33908024-26B7CEC4-686A-44CF-8010-B13FBBAD188F

P577

Q33908024-F158097B-C506-4BB4-82F8-9458F30C75B8

P5875

Q33908024-242D9CCD-9E58-4148-B7C0-A522699E0BF5

P698

Q33908024-1C79CA48-4DBF-40AC-A3CC-83EEC139D4AF

P921

Q33908024-AE7C067B-3574-417A-9B0B-359B2676941A

P932

Q33908024-B120B31B-6D68-42B4-A6E6-11779239FC5D

P356

J.CCR.2014.05.002

P1433

P1476

Hematogenous metastasis of ovarian cancer: rethinking mode of spread.

@en

P2093

Alpa M Nick

http://www.w3.org/2001/XMLSchema#string

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Behrouz Zand

http://www.w3.org/2001/XMLSchema#string

Carolyn S Hall

http://www.w3.org/2001/XMLSchema#string

Chad V Pecot

http://www.w3.org/2001/XMLSchema#string

Farideh Z Bischoff

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

Heather J Dalton

http://www.w3.org/2001/XMLSchema#string

Hee Dong Han

http://www.w3.org/2001/XMLSchema#string

Ho Jeong Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation

Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274

A phase 3 trial of bevacizumab in ovarian cancer.

Targeted gene silencing using RGD-labeled chitosan nanoparticles.

Regulation of tumor angiogenesis by EZH2.

NetWalker: a contextual network analysis tool for functional genomics

A novel platform for detection of CK+ and CK- CTCs.

P304

77-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2014.05.002

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Cristian Rodriguez-Aguayo

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264632874

http://www.w3.org/2001/XMLSchema#string

P698

25026212

http://www.w3.org/2001/XMLSchema#string

P921

P932

4100212

http://www.w3.org/2001/XMLSchema#string